About FAST

FAST Australia launched in September 2010. Inspired by the mission and energy of FAST in the United States we are driven to address the lack of research and understanding into Angelman syndrome in Australia. Our combined energies create a powerful force in the search for therapeutic interventions and a cure to treat Angelman syndrome. 

In an age where Angelman syndrome therapeutics are being developed on a global scale, FAST is working to make sure communities across the world are organized and prepared to participate in studies for potential therapeutics. FAST has affiliates in  Canada, France, Italy, Latin America (Argentina, Chile, Colombia), Spain and the UK.


FAST has a vision of a world where lives are no longer limited by a diagnosis of Angelman syndrome.

The mission of the Foundation for Angelman Syndrome Therapeutics Australia is to improve the quality of life for individuals with Angelman syndrome through timely diagnosis, access to best practices in care and treatments, and advancing research for a cure.


FAST Australia are overseen by Board of Directors who work with a Chief Executive Officer to utilise their expertise in various fields to advance our mission, assess our strategies and create opportunities to aggressively pursue our goals. Our science is vetted by a Scientific Advisory Board (or SAB) consisting of recognised clinicians and scientists considered experts in their respective fields


As an Australian business, and a Health Promotion Charity with DGR status we realise that transparency is vitally important to our members. 

FAST Australia was established in 2010.

We are registered with the Australian Charities and Not-for-Profits Commission (ACNC). Our listing, with up to date financials, can be found here.

Australian founding board members Joanne Davis & Jennifer Kyriacou at the Foundation launch Oct 2010.